Navigation Links
Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Date:10/25/2011

6.7.7 SMC 021 94

6.7.8 Ostora 94

6.7.9 BA058- injection 96

6.7.10 UNI-PH (1-34), rhPTH 1-34 96

6.7.11 YM529 / ONO-5920 --- Astellas/ ONO 97

6.8 Key Takeaway 97

7 Osteoporosis Therapeutics: Clinical Trials Mapping 98

7.1 Clinical Trials by Region/Country (The US, EU5 and Japan) 98

7.2 Clinical Trials by Phase of Clinical Development 99

7.3 Clinical Trials by Trial Status 100

7.4 Prominent Sponsors 101

7.5 Clinical Trials by Sponsors 102

7.6 Top Companies Participating in Osteoporosis Therapeutics Clinical Trials 103

8 Osteoporosis Therapeutics: Strategic Assessment 105

8.1 Key Events Impacting the Future Market 105

8.2 Future Market Competition Scenario 105

9 Osteoporosis Therapeutics: Future Players 108

9.1 Introduction 108

9.2 Company Profiles 108

9.2.1 Amgen Inc. 108

9.2.2 Astellas Pharma, Inc. 111

9.2.3 EffRx, Inc. 113

9.2.4 Merck & Co., Inc. 114

9.2.5 Novartis AG 115

9.2.6 Osteologix, Inc. 117

9.2.7 Pfizer Inc. 118

9.2.8 Radius Health, Inc 122

9.2.9 Tarsa Inc. 123

9.2.10 Zyduscadila Inc. 123

9.3 Other Companies in the Osteoporosis Therapeutics Market 126

9.4 Key Takeaway 129

10 Osteoporosis Therapeutics: Licensing & Partnership Deals 129

11 Osteoporosis Therapeutics: Appendix 140

11.1 Market Definitions 140

11.2 Abbreviations 140

11.3 Research Methodology 142

11.3.1 Coverage 142

11.3.2 Secondary Research 142

11.3.3 Forecasting 143

11.3.4 Primary Research 145

11.3.5 Expert Panel Validation 146

11.4 Contact Us 146

11.5 Disclaimer 146

11.6 Bibliography 147

List of Tables

Table 1: Difference Between Type I and Type II Osteoporosis 19

Table 2: Osteoporosis Prevalence and Low Bone Mass in People Aged 50 and Over (The US) (million
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Zosano Pharma, Inc. and Asahi Kasei Pharma Corporation Enter Exclusive Licensing Agreement for a Weekly Transdermal Patch Formulation of Teribone™ (teriparatide acetate) for Osteoporosis
2. Womens Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets
3. Tarsa Therapeutics Presents Positive Efficacy and Safety Data Comparing Its Oral Calcitonin to Nasal Calcitonin and Placebo in Phase III Osteoporosis Treatment Trial
4. Lilly Announces Review of Data on Long-Term Raloxifene Treatment for Postmenopausal Osteoporosis Published in Current Medical Research & Opinion
5. Radius, 3M Drug Delivery Systems Sign Development Agreement for Transdermal Delivery of BA058 for Treatment of Osteoporosis
6. Amgen and UCB Announce Positive Phase 2 Results of AMG 785/CDP7851 in Patients With Postmenopausal Osteoporosis (PMO)
7. Tarsa Therapeutics Reports Positive Top-Line Results From Pivotal Phase III ORACAL Trial of its Oral Calcitonin in Treatment of Postmenopausal Osteoporosis
8. ICAP Ocean Tomo Announces Patents for a New and Safer Method of Treatment of Osteoporosis and Tumor Metastasis Using a Novel Zoledronic Acid Combination
9. Commonly Prescribed Osteoporosis Drug Associated with Very Low Risk of Serious Jaw Disease
10. Tarsa Therapeutics Completes Phase III Trial of its Oral Calcitonin for Treatment of Postmenopausal Osteoporosis and Initiates Phase II Trial in Osteoporosis Prevention
11. $1,700,000 Funding of NeoStems Very Small Embryonic-Like Stem Cells Being Developed to Treat Osteoporosis Recommended by the Department of Defense Peer Reviewed Medical Research Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... LOS ANGELES , July 11, 2014 /PRNewswire-iReach/ ... of e-liquid, a vegetable-glycol solution for use in ... one of the active ingredients in cannabis, cannabidiol ... in personal vaporizer devices, and other vaporizer technology. ... Cannabis naturally contains 483 different compounds ...
(Date:7/11/2014)... 2014 Patient engagement has become a ... are turning to an assortment of marketing activities ... of this evolving approach to patient engagement, marketers ... engage patients throughout their experiences with a disease ... mapping the patient journey and employing a consumer ...
(Date:7/11/2014)... , July 11, 2014 The ... are evolving across industry sectors to better identify ... better ways to engage with and understand consumers, ... themselves and make critical purchasing decisions. ... Best Practices, LLC, one area where organizations can ...
Breaking Medicine Technology:VAPETEK Releases CBD-Infused eLiquid For The Consumer Market 2New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2New Technologies Transforming Consumer Marketing Research Playbook 2
... Medical Tactile, Inc. and Valentus Medical Technologies, Inc. ... , Canada , has signed a partnership agreement with Medical Tactile, ... SureTouch™ , the non-invasive digital breast imaging technology, worldwide, with the ... , , ...
... July 13 Amira Pharmaceuticals, Inc. today announced that the ... Activating Protein (FLAP) Inhibitors," which includes coverage of Amira,s AM103 and ... , , ... , Amira and GlaxoSmithKline (GSK) entered into a worldwide exclusive agreement ...
Cached Medicine Technology:Partnership Brings Breast Image Documentation Technology to Women Around the World 2Amira Announces AM103 and AM803 Patent Grant in the United Kingdom 2
(Date:7/12/2014)... 12, 2014 Wright & Schulte LLC has ... , Inc., a subsidiary of Johnson & Johnson, on behalf ... pain after receiving a metal-on-metal DePuy Pinnacle hip replacement and ... the artificial hip implant. The DePuy hip lawsuit was filed ... of Texas (Case No. 3:14-cv-2427) where DePuy Pinnacle Hip ...
(Date:7/12/2014)... 2014 “Critical Care Therapeutics in ... Late-Stage Four-Factor PCCs and Recombinant Products to Drive ... care market in the US, UK, France, Germany, ... an estimation of market size for 2013, along ... care indications that are being treated using the ...
(Date:7/12/2014)... Doylestown Hospital recently conducted an interview with ... questions. Paddock tackles topics including main men's health ... longer than men, and testosterone replacement therapy, among others. ... featured on Doylestown Hospital’s website, Dr. Brad Paddock says, ... If you notice pain, bulging, or asymmetry in your ...
(Date:7/12/2014)... 12, 2014 As reported in this ... Standards and Technology), the June 25th, 2014 Supreme Court ruling ... world. It was also met with both cheers ... whether it was seen from an individual privacy perspective, or ... fact, there is now precedent which will require law enforcement ...
(Date:7/12/2014)... Salt Lake City, Utah (PRWEB) July 12, 2014 ... Five spotlighted two types of startups, with awards being ... UVEF’s new emphasis spotlighted Utah’s outstanding entrepreneur community with ... are proving a sustainable model with incoming revenue. , ... companies from across the state that are under 5 ...
Breaking Medicine News(10 mins):Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 2Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 3Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 4Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 5Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 2Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 3Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 4Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 5Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 6Health News:Ivyland Medical Center’s Dr. Brad Paddock Offers Tips for Men’s Health 2Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 2Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 3Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 4Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 5Health News:SquareHook is Recognized for UVEF 25 Businesses Under 5 Years-Watch Out 2
... to a multitude of complications if left untreated. A ... of using tea as a form of treatment for ... to prevent the incidence of cataracts, a significant health ... ,Researchers developed special rats with diabetes. This provided ...
... Apollo Hospitals Group has been shortlisted by Britain's National Health ... UK where it could provide diagnostic services.// ,Long waiting ... of its operations to cut the delay faced by its ... radiology, including CT scan, MRIs, X-rays, endoscopy, ultra-sound and so ...
... stress during early life can lead to an increased ... It therefore, highlights the need for a counseling for ... growth. ,Several studies have established a relationship ... an increased risk of developing attachment disorders. These children ...
... at Harvard University, who say that these proteins and ... key to oncogenesis,// the process of formation of cancer ... protein known to cause cancer, is activated and becomes ... the hypothesis that an important component of oncogenesis is ...
... published in the Journal of the National Cancer Institute ... the link between diabetes and the prevalence and associated ... Susanna C. Larsson, M.Sc., of the Karolinska Institute in ... meant that individuals were at a 30 percent risk ...
... a very common disease of the present times; it is ... by way of incorporating specific foods has been found to ... clues for future diabetes treatment, following a doctor's advice on ... course of action and researchers are constantly on the lookout ...
Cached Medicine News:Health News:Apollo Hospitals Short-listed to Provide Diagnostics in the UK 2Health News:Teenage Mental Problems Could Be The Result Of Stress During Early Life 2Health News:Diet Effective In Curing Diabetes 2
Hydrophobic PE filter without self-sealing additives, permits sample recovery after accidental over-pipetting. All filters are sterile (to USP, DAB, Ph.Eur. standards) and PCR clean (free from human ...
... Resistant Tips offer a safe alternative to ... designed for applications such as PCR(a), pipetting ... ART Tips are excellent for tissue culture, ... ART Tips prevent aerosol contaminants and liquids ...
... Filters are ideal for ... methods, or for any ... might occur. They are ... solutions, infectious materials, labelled ...
Inquire...
Medicine Products: